Aliskiren Prevents the Toxic Effects of Peritoneal Dialysis Fluids during Chronic Dialysis in Rats

• Juan Pérez-Martínez,

  Affiliation Department of Nephrology, Complejo Hospitalario Universitario, Albacete, Spain

  ⨯
• Francisco C. Pérez-Martínez,

  Affiliation Department of Research and Development, NanoDrugs, S.L., Parque Científico y Tecnológico, Albacete, Spain

  ⨯
• Blanca Carrión,

  Affiliation Department of Research and Development, NanoDrugs, S.L., Parque Científico y Tecnológico, Albacete, Spain

  ⨯
• Jesús Masiá,

  Affiliation Department of Nephrology, Complejo Hospitalario Universitario, Albacete, Spain

  ⨯
• Agustín Ortega,

  Affiliation Department of Nephrology, Complejo Hospitalario Universitario, Albacete, Spain

  ⨯
• Esther Simarro,

  Affiliation Department of Clinical Chemistry, Complejo Hospitalario Universitario, Albacete, Spain

  ⨯
• Syong H. Nam-Cha,

  Affiliation Department of Pathology, Complejo Hospitalario Universitario, Albacete, Spain

  ⨯
• Valentín Ceña

  * E-mail: valentin.cena@gmail.com

  Affiliations Unidad Asociada Neurodeath, Departamento de Ciencias Médicas, CSIC-Universidad de Castilla-La Mancha, Albacete, Spain, CIBERNED, Instituto de Salud Carlos III, Madrid, Spain

  ⨯